1 Min Read
March 21 (Reuters) - Gilead Sciences Inc -
* British Columbia lists EPCLUSA on public drug plan to treat all six genotypes of chronic hepatitis C infection Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.